Identification of cis-acting elements involved in Acetylcholinesterase RNA alternative splicing

Molecular and Cellular Neuroscience

Volumn 38, Issue 1, 2008, Pages 1-14

  Guerra, Manuel ^a,b   Dobbertin, Alexandre ^a,b   Legay, Claire ^a,b  

^a ECOLE NORMALE SUPÉRIEURE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Acetylcholinesterase; Alternative splicing; Branch point; cis acting sequences; Muscle; SC35

Indexed keywords

ACETYLCHOLINESTERASE; MESSENGER RNA;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN COS7; ENZYME ANALYSIS; ENZYME CONFORMATION; EXON; GENE CONSTRUCT; GENE MUTATION; GENETIC TRANSFECTION; INTRON; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; RNA SEQUENCE; SEDIMENTATION RATE; SKELETAL MUSCLE;

ACETYLCHOLINESTERASE; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RNA PRECURSORS; RNA SPLICE SITES; TRANS-ACTIVATORS;

EID: 43049106402     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.01.007     Document Type: Article

References (56)

1. Atanasova E., Chiappa S., Wieben E., and Brimijoin S. Novel messenger RNA and alternative promoter for murine acetylcholinesterase. J. Biol. Chem. 23 (1999) 21078-21084
2. Belbeoc'h S., Massoulié J., and Bon S. The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway. Embo J. 22 (2003) 3536-3545
3. Boelens W.C., Jansen E.J., van Venrooij W.J., Stripecke R., Mattaj I.W., and Gunderson S.I. The human U1 snRNP-specific U1A protein inhibits polyadenylation of its own pre-mRNA. Cell 72 (1993) 881-892
4. Bon S., and Massoulié J. Quaternary associations of acetylcholinesterase. I. Oligomeric associations of T subunits with and without the amino-terminal domain of the collagen tail. J. Biol. Chem. 272 (1997) 3007-3015
5. Bon S., Dufourcq J., Leroy J., Cornut I., and Massoulié J. The C-terminal t peptide of acetylcholinesterase forms an alpha helix that supports homomeric and heteromeric interactions. Eur. J. Biochem. 271 (2004) 33-47
6. Brenner T., Hamra-Amitay Y., Evron T., Boneva N., Seidman S., and Soreq H. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J. 17 (2003) 214-222
7. Caceres J.F., Stamm S., Helfman D.M., and Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265 (1994) 1706-1709
8. Chan R.C., and Black D.L. Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro. Mol. Cell. Biol. 15 (1995) 6377-6385
9. Chan R.Y.Y., Adatia F.A., Krupa A.M., and Jasmin B. Increased expression of Acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J. Biol. Chem. 273 (1998) 9727-9733
10. Charlet B.N., Logan P., Singh G., and Cooper T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9 (2002) 649-658
11. Coleman B.A., and Taylor P. Regulation of acetylcholinesterase expression during neuronal differentiation. J. Biol. Chem. 271 (1996) 4410-4416
12. Cote J., Dupuis S., Jiang Z., and Wu J.Y. Caspase-2 pre-mRNA alternative splicing: identification of an intronic element containing a decoy 3′ acceptor site. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 938-943
13. Coussen F., Ayon A., Le Goff A., Leroy J., Massoulié J., and Bon S. Addition of a glycophosphatidylinositol to acetylcholinesterase. Processing, degradation, and secretion. J. Biol. Chem. 276 (2001) 27881-27892
14. Darreh-Shori T., Hellstrom-Lindahl E., Flores-Flores C., Guan Z.Z., Soreq H., and Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J. Neurochem. 88 (2004) 1102-1113
15. Deschenes-Furry J., Belanger G., Mwanjewe J., Lunde J.A., Parks R.J., Perrone-Bizzozero N., and Jasmin B.J. The RNA-binding protein HuR binds to acetylcholinesterase transcripts and regulates their expression in differentiating skeletal muscle cells. J. Biol. Chem. 280 (2005) 25361-25368
16. Deschenes-Furry J., Mousavi K., Bolognani F., Neve R.L., Parks R.J., Perrone-Bizzozero N.I., and Jasmin B.J. The RNA-binding protein HuD binds acetylcholinesterase mRNA in neurons and regulates its expression after axotomy. J. Neurosci. 27 (2007) 665-675
17. Dirksen W.P., Sun Q., and Rottman F.M. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J. Biol. Chem. 270 (1995) 5346-5352
18. Dvir H., Harel M., Bon S., Liu W.Q., Vidal M., Garbay C., Sussman J.L., and Massoulié J. The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix. Embo J. 23 (2004) 4394-4405
19. Fu X.D. Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature 365 (1993) 82-85
20. Futerman A.H., Fiorni R.M., Roth E., Low M.G., and Silman I. Physicochemical behavior and structural characteristics of membrane bound acetylcholinesterase from Torpedo electric organ. Effect of Phosphatidylinositol-Specific Phospholipase C (1985)
21. Goux-Pelletan M., Libri D., d'Aubenton-Carafa Y., Fiszman M., Brody E., and Marie J. In vitro splicing of mutually exclusive exons from the chicken beta-tropomyosin gene: role of the branch point location and very long pyrimidine stretch. Embo J. 9 (1990) 241-249
22. Gromak N., and Smith C.W. A splicing silencer that regulates smooth muscle specific alternative splicing is active in multiple cell types. Nucleic Acids Res. 30 (2002) 3548-3557
23. Gromak N., Matlin A.J., Cooper T.A., and Smith C.W. Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. Rna 9 (2003) 443-456
24. Grossman J.S., Meyer M.I., Wang Y.C., Mulligan G.J., Kobayashi R., and Helfman D.M. The use of antibodies to the polypyrimidine tract binding protein (PTB) to analyze the protein components that assemble on alternatively spliced pre-mRNAs that use distant branch points. Rna 4 (1998) 613-625
25. Guo W., Mulligan G.J., Wormsley S., and Helfman D.M. Alternative splicing of beta-tropomyosin pre-mRNA: cis-acting elements and cellular factors that block the use of a skeletal muscle exon in nonmuscle cells. Genes Dev. 5 (1991) 2096-2107
26. Helfman D.M., and Ricci W.M. Branch point selection in alternative splicing of tropomyosin pre-mRNAs. Nucleic Acids Res. 17 (1989) 5633-5650
27. Kaufer D., Friedman A., Seidman S., and Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393 (1998) 373-377
28. Krejci E., Thomine S., Boschetti N., Legay C., Sketelj J., and Massoulie J. The mammalian gene of acetylcholinesterase-associated collagen. J. Biol. Chem. 272 (1997) 22840-22847
29. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 488-492
30. Legay C. Why so many forms of acetylcholinesterase?. Microsc. Res. Tech. 49 (2000) 56-72
31. Legay C., Bon S., and Massoulie J. Expression of a cDNA encoding the glycolipid-anchored form of rat acetylcholinesterase. FEBS Lett. 315 (1993) 163-166
32. Legay C., Huchet M., Massoulie J., and Changeux J.P. Developmental regulation of acetylcholinesterase transcripts in the mouse diaphragm: alternative splicing and focalization. Eur. J. Neurosci. 7 (1995) 1803-1809
33. Legay C., Mankal F.A., Massoulie J., and Jasmin B.J. Stability and secretion of acetylcholinesterase forms in skeletal muscle cells. J. Neurosci. 19 (1999) 8252-8259
34. Li Y., Camp S., Rachinsky T.L., Getman D., and Taylor P. Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression. J. Biol. Chem. 266 (1991) 23083-23090
35. Li Y., Camp S., and Taylor P. Tissue-specific expression and alternative mRNA processing of the mammalian acetylcholinesterase gene. J. Biol. Chem. 268 (1993) 5790-5797
36. Luo Z.D., Camp S., Mutero A., and Taylor P. Splicing of 5′ introns dictates alternative splice selection of acetylcholinesterase pre-mRNA and specific expression during myogenesis. J. Biol. Chem. 273 (1998) 28486-28495
37. Massoulié J. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11 (2002) 130-143
38. Mayeda A., and Krainer A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68 (1992) 365-375
39. Meshorer E., Erb C., Gazit R., Pavlovsky L., Kaufer D., Friedman A., Glick D., Ben-Arie N., and Soreq H. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295 (2002) 508-512
40. Meshorer E., Toibert D., Zurel D., Sahly I., Dori A., Cagnano E., Schreiber L., Grisaru D., Tronche F., and Soreq H. Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products. J. Biol. Chem. 279 (2004) 29740-29751
41. Meshorer E., Bryk B., Toiber D., Cohen J., Podoly E., Dori A., and Soreq H. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Mol. Psychiatry 10 (2005) 985-997
42. Millevoi S., Geraghty F., Idowu B., Tam J.L., Antoniou M., and Vagner S. A novel function for the U2AF 65 splicing factor in promoting pre-mRNA 3′-end processing. EMBO Rep. 3 (2002) 869-874
43. Mizushima S., and Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18 (1990) 5322
44. Niwa M., Rose S.D., and Berget S.M. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 4 (1990) 1552-1559
45. Noble M., Groves A.K., Ataliotis P., Ikram Z., and Jat P.S. The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines. Transgenic Res. 4 (1995) 215-225
46. Perrier A.L., Massoulie J., and Krejci E. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33 (2002) 275-285
47. Perrier N.A., Salani M., Falasca C., Bon S., Augusti-Tocco G., and Massoulié J. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo. J. Neurochem. 94 (2005) 629-638
48. Shen H., Kan J.L., and Green M.R. Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol. Cell 13 (2004) 367-376
49. Silman I., and Sussman J.L. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Curr. Opin. Pharmacol. 5 (2005) 293-302
50. Singh R., Valcarcel J., and Green M.R. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268 (1995) 1173-1176
51. Smith C.W., and Nadal-Ginard B. Mutually exclusive splicing of alpha-tropomyosin exons enforced by an unusual lariat branch point location: implications for constitutive splicing. Cell 56 (1989) 749-758
52. Soreq H., and Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev., Neurosci. (2001)
53. Southby J., Gooding C., and Smith C.W. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutually exclusive exons. Mol. Cell. Biol. 19 (1999) 2699-2711
54. Staffa A., and Cochrane A. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15 (1995) 4597-4605
55. Tacke R., and Manley J.L. Determinants of SR protein specificity. Curr. Opin. Cell. Biol. 11 (1999) 358-362
56. Taylor P., and Radic Z. The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34 (1994) 281-320